Page 1
1
Oncologic Emergencies
Francis L. Counselman, M.D., CPE, FACEP
Department of Emergency Medicine
Eastern Virginia Medical School
Norfolk, Virginia
Superior Vena Cava Syndrome
Compression of SVC by mediastinal or pulmonary mass or intraluminal occlusion by thrombosis
Page 2
2
Epidemiology
• Male:Female ratio 2.5:1
• Average age 56yo
• Approx 60% of patients without history of cancer
Incidence
• 5-15% of all Lung CA
• 5% of all Lymphomas
• 1% of all Pulmonary Mets
Page 3
3
Etiology
• Malignancy: Most common
• Mediastinal fibrosis
• Aortic aneurysm
• Granulomatous infection
• Goiter
• Iatrogenic: 20-40%
• Radiation fibrosis
Malignancies and SVC
• Lung 75%
• Lymphoma 10-15%
• Metastatic 10%
• Breast
• Thymus
• Testicular
Page 4
4
Symptoms
• Gradual onset
• Malignancy: more rapid progression
• Benign: slower progression
• 75% have signs/symptoms more than one week
• Symptoms worse upon awakening
Symptoms
• Headache 80%
• Dyspnea 65%
• Cough 55%
• Nausea/vomiting
• Dysphagia
• Tightness of shirt collar
• Visual changes
Page 5
5
Symptoms
• Altered mental status
• Syncope
• Swollen arms
• Hoarseness
• Orthopnea
• Stridor
• Seizure
• Weight loss
Physical Exam
• Dilated neck veins 80%
• Thoracic vein distention 74%
• Face/upper torso edema 70%
• Cyanosis of upper body 44%
• Plethora 14%
Page 7
7
Physical Exam
• Worsening of symptoms with arms above head (Pemberton’s sign)
• Paralyzed true vocal cords
• Tachypnea
• Horners syndrome
• Abdominal vein distention
Page 8
8
Imaging
• CXR
• Venogram
• Radionuclide scan
• Contrast chest CT scan
• Ultrasound
• Echocardiography
• MRI
Page 9
9
CXR
• Mediastinal widening 64%
• Pleural effusion 25%
• Right hilar mass
• Bilateral diffuse infiltrates
Page 10
10
CXR
• Cardiomegaly
• Anterior mediastinal mass
• Upper lobe collapse
• Calcified paratracheal
nodes
Normal CXR in 16% of SVC Syndrome
Page 11
11
Venogram
• Gold standard (old)
• Advantages
• Disadvantages
Contrast Chest CT Scan
• 92% sensitivity; 96% specificity
• Location/extent of tumor or thrombus
• Info for needle biopsy
• Plan radiation portals
Page 12
12
Ultrasound of Subclavian Veins
• Quick, noninvasive, inexpensive and no radiation
• Indirect evaluation of SVC patency
Echocardiography
• Transesophageal
• Bedside procedure
• No contrast material
• Differentiates between intravascular obstruction and extravascular compression
Page 13
13
Magnetic Resonance Imaging
• Contrast
• 94% sensitivity
• 100% specificity
• Limited use
Page 14
14
Management
• Initiate diagnostic workup
• Can better plan appropriate treatment with histologic diagnosis
Management
• Elevate head of bed
• Oxygen
• Steroids?
• Diuretics
• IV access
Page 15
15
Management
• Upper airway obstruction
• Cerebral edema
Rare but life-threatening
Require endovenous stent placement
and radiation therapy
Management
• Radiation therapy
• Subjective response within 72h
• Objective response within 7 to 14 days
Page 16
16
Management
• Thrombolytic therapy/Anticoagulation
• Common with indwelling catheters
• Contraindicated if brain mets
Management
• Chemotherapy
• Surgery
• Endovascular stents
Page 17
17
Hypercalcemia of Malignancy
• Most common metabolic complication
• Occurs in 10-30% of all CA patients
• In ED: malignancy (44%) followed by hyperparathyroidism (20%)
Differential Diagnosis
PAM P SCHMIDT
Page 18
18
Primary Diagnosis
• PrimaryHyperparathroidism
• Addisons Disease
• Multiple Myeloma
• Pagets Disease
Differential Diagnosis
• Sarcoidosis
• Cancer
• Hyperthyroidism
• Mild-Alkali Syndrome
• Immobilization
• D Vitamin Toxicity
• Thiazide Diuretics
Page 19
19
Pathophysiology
• Tumor secretion of PTH-related protein
• Responsible 80% of time• Stimulates osteoclast mediated bone resorption
• Stimulates renal tubular reabsorption of calcium
Pathophysiology
• Local bone destruction from mets with osteoclast activating factors
• Tumor production of Vitamin D analogues
Page 20
20
Solid Tumors with Bone Mets
• Breast 42%
• Lung 15%
• Prostate
Clinical Presentation
• Consider in all patients with malignant disease who feel sick
• Bones, stones, moans and groans
Page 21
21
Clinical Presentation
• Weakness
• Lethargy
• Fatigue
• Dehydration
Gastrointestinal
• Anorexia
• Nausea/vomiting
• Constipation
• Abdominal pain
• Obstipation
• Ileus
Page 22
22
Renal
• Polyuria
• Polydypsia
• Dehydration
• Nocturia
• Nephrolithiasis
• Nephrocalcinosis
Neurologic
• Anxiety
• Agitation
• Depression
• Impaired concentration
• Fatigue
Page 23
23
Neurologic
• Increased sleep requirements
• Altered level of consciousness*
• Decreased DTRs
• Ataxia
Cardiovascular
• Hypertension
• Arrhythmias
• Vascular calcifications
• EKG abnormalities
• Digitalis sensitivity
Page 24
24
Musculoskeletal
Bone pain
Diagnosis
• Serum calcium
• EKG
• Urinalysis
• Serum chloride
• Parathyroid hormone (PTH)
Page 25
25
Serum Calcium
• Asymptomatic < 12mg/dl
• pH
• Albumin level
• Rate of rise
Serum Calcium
• Ionized serum calcium level
• If measure total calcium:
Corrected Ca =
measured Ca + (0.8 x [4-albumin])
• Moderate: 12 to 14 mg/dl
• Severe: >14mg/dl
Page 26
26
EKG
• QT interval shortening
• Prolongation of PR
• Prolongation of QRS
• AV block
• Coving of ST-T segments
Page 27
27
Urinalysis
• Decreased specific gravity
• Increased glucose
• Increased Na
• Increased K
• Increased Mg
• Proteinuria
Serum Chloride
• Cl <100mEQ/L indicates hypercalcemia secondary to PTHrP
• Less responsive to bisphosphonates
Page 28
28
Parathyroid Hormone (PTH)
- Level < 20pg/mL not consistent with primary hyperparathyroidism
- If negative, consider ordering PTH-related peptide (PTHrp)
Management
• Treat underlying cause
• Rehydration
• Diuresis
• Electrolyte balance
• Specific measures
Page 29
29
Treatment
• Asymptomatic or mildly symptomatic with Ca <12mg/dL does not require immediate treatment
• Level >14mg/dL requires treatment, regardless of symptoms
Rehydration
• IV NS 200 to 500 cc/hr
• 100 to 150 cc/hr urine output
Page 30
30
Diuresis
• Rehydrate first
• Lasix no longer routine
• Consider if edema
or CHF
Electrolyte Balance
• Potassium
• Magnesium
Page 31
31
Calcitonin
• Increases renal calcium excretion.
• Decreases bone resorption
• Fast acting
• 4 IU/kg IM or SQ
• If responds, repeat every 6 to 12 hours
Bisphosphonates
• First line therapy
• Inhibits osteoclast mediated bone resorption
• More potent than calcitonin
• Max effect in 2-4 days
Page 32
32
Bisphosphonates
• Zoledronic acid 4mg IV over 15min*
• Pamidronate 60-90mg IV over 2 to 4 hours
Management
• Concurrent administration
• IV NS
• Calcitonin IM or SQ
• Zoledronic acid (ZA) IV
Page 33
33
Dialysis
• Hemodialysis
• Peritoneal dialysis
• Renal failure
Spinal Cord Compression
• 5% of all CA patients
• Peak age: 55 to 65yo
• 80% have dx of CA
• Prognosis time dependent
• First described in 1925
Page 34
34
Sites of Metastasis
• 60% Thoracic
• 30% Lumbosacral
• 10% Cervical
Location of Metastasis
• Vertebral column 90%
• Paravertebral space 10%
• Epidural space < 5%
Page 35
35
Primary Cancer
• Breast 20 to 30%
• Lung 15 to 20%
• Prostate 15 to 20%
• Lymphoma
• Renal
• Multiple myeloma
Back Pain
• 95% of cases
• Gradual and progressive
• Precedes other symptoms by 2 months
• Dull, aching, constant
• DJD v Metastatic disease
Page 36
36
Pain
• Localized initially
• Referred or radicular
• Increased with cough, sneeze, weight bearing
• Pain at night
Clinical Presentation
• Numbness
• Parasthesias
• Coldness
Page 37
37
Clinical Presentation
• Autonomic dysfunction
• Indicates T10-T12 involvement
• Present 50% at time of diagnosis
• Poor prognostic sign
Clinical Presentation
• Weakness
• Initial complaint 36%
• Very poor prognostic sign
Page 38
38
Physical Exam
• Vertebral tenderness 33%
• Straight leg raise
• Neck flexion
• Neurologic exam• hyperresponsive DTRs
Page 39
39
Diagnosis
• Plain films
• Myelogram
• Bone scan
• Spinal CT scan
• MRI
Plain Films
• 80% sensitivity
• Vertebral body collapse
• Osteolytic lesion
• Osteoblastic lesion
• Paraspinal mass
Page 40
40
Spinal CT Scan
• Transaxial plane only
• Excellent detail
• Preferred with myelogram
Page 41
41
Magnetic Resonance Imaging
• Gold standard
• 95% accuracy
• No contrast material
• No ionizing radiation
• Images in multiple plains
Page 42
42
Imaging Guidelines for Patient with history of CA and Back Pain
• High suspicion or abnormal neuro exam – emergent
• Low suspicion and normal neuro exam – outpatient imaging within 48 to 72 hours and consult
Management
• Consultation
• Steroids
• Radiation
• Surgery
• Chemotherapy
Page 43
43
Steroids
• Relieves pain
• Reduces edema
• Reduces inflammation
• Short-term benefit
Dexamethasone
• 10mg IV bolus then 16 mg/day (bid to QID)
• If dense paresis, consider 96 mg IV, then 24mg IV QID
Page 44
44
Radiation Therapy
• Definitive treatment
• Pain relief in 70 to 80% of cases
• Better prognosis if initiated prior to paraplegia
Radiation Therapy
81% ambulatant pretreat remained ambulatory post RT
17% nonambulant pretreat became ambulatory post RT
73% had improvement in pain
Page 45
45
Surgery
• Decompress spinal cord and nerve roots• Radiation therapy• Indications in development
Chemotherapy
• Rarely helpful